Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2026-01-01 @ 11:37 AM
Study NCT ID:
NCT05665192
Status:
COMPLETED
Last Update Posted:
2025-04-08
First Post:
2022-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-24
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-16
First Submit QC Date:
None
Study First Post Date:
2022-12-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-04
Last Update Post Date:
2025-04-08
Last Update Post Date Type:
ACTUAL